BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 9858429)

  • 1. Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
    Barry NN; McGuire JL; van Vollenhoven RF
    J Rheumatol; 1998 Dec; 25(12):2352-6. PubMed ID: 9858429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months.
    van Vollenhoven RF; Morabito LM; Engleman EG; McGuire JL
    J Rheumatol; 1998 Feb; 25(2):285-9. PubMed ID: 9489820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial.
    Chang DM; Lan JL; Lin HY; Luo SF
    Arthritis Rheum; 2002 Nov; 46(11):2924-7. PubMed ID: 12428233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.
    Nordmark G; Bengtsson C; Larsson A; Karlsson FA; Sturfelt G; Rönnblom L
    Autoimmunity; 2005 Nov; 38(7):531-40. PubMed ID: 16373258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.
    Petri MA; Mease PJ; Merrill JT; Lahita RG; Iannini MJ; Yocum DE; Ginzler EM; Katz RS; Gluck OS; Genovese MC; Van Vollenhoven R; Kalunian KC; Manzi S; Greenwald MW; Buyon JP; Olsen NJ; Schiff MH; Kavanaugh AF; Caldwell JR; Ramsey-Goldman R; St Clair EW; Goldman AL; Egan RM; Polisson RP; Moder KG; Rothfield NF; Spencer RT; Hobbs K; Fessler BJ; Calabrese LH; Moreland LW; Cohen SB; Quarles BJ; Strand V; Gurwith M; Schwartz KE
    Arthritis Rheum; 2004 Sep; 50(9):2858-68. PubMed ID: 15452837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.
    Petri MA; Lahita RG; Van Vollenhoven RF; Merrill JT; Schiff M; Ginzler EM; Strand V; Kunz A; Gorelick KJ; Schwartz KE;
    Arthritis Rheum; 2002 Jul; 46(7):1820-9. PubMed ID: 12124866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of pregnenolone and 17-hydroxypregnenolone in patients with rheumatoid arthritis and systemic lupus erythematosus: relation to other adrenal hormones.
    Vogl D; Falk W; Dorner M; Schölmerich J; Straub RH
    J Rheumatol; 2003 Feb; 30(2):269-75. PubMed ID: 12563679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial.
    Hartkamp A; Geenen R; Godaert GL; Bijl M; Bijlsma JW; Derksen RH
    Ann Rheum Dis; 2010 Jun; 69(6):1144-7. PubMed ID: 19854713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.
    Straub RH; Zeuner M; Antoniou E; Schölmerich J; Lang B
    J Rheumatol; 1996 May; 23(5):856-61. PubMed ID: 8724298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of dehydroepiandrosterone (DHEA) as a therapeutic agent in systemic lupus erythematosus.
    Van Vollenhoven RF; McGuire JL
    Ann Med Interne (Paris); 1996; 147(4):290-6. PubMed ID: 8952750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women.
    Genazzani AR; Pluchino N; Begliuomini S; Stomati M; Bernardi F; Pieri M; Casarosa E; Palumbo M; Genazzani AD; Luisi M
    Gynecol Endocrinol; 2006 Nov; 22(11):627-35. PubMed ID: 17145649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus.
    Chang DM; Chu SJ; Chen HC; Kuo SY; Lai JH
    Ann Rheum Dis; 2004 Dec; 63(12):1623-6. PubMed ID: 15547086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.
    Overman CL; Hartkamp A; Bossema ER; Bijl M; Godaert GL; Bijlsma JW; Derksen RH; Geenen R
    Lupus; 2012 Dec; 21(14):1515-21. PubMed ID: 22936125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Straub RH; Weidler C; Demmel B; Herrmann M; Kees F; Schmidt M; Schölmerich J; Schedel J
    Ann Rheum Dis; 2004 Aug; 63(8):961-8. PubMed ID: 15249323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
    Khaw KT
    J Endocrinol; 1996 Sep; 150 Suppl():S149-53. PubMed ID: 8943798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women.
    Cappel M; Mauger D; Thiboutot D
    Arch Dermatol; 2005 Mar; 141(3):333-8. PubMed ID: 15781674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Härle P; Pongratz G; Weidler C; Büttner R; Schölmerich J; Straub RH
    Ann Rheum Dis; 2004 Jul; 63(7):809-16. PubMed ID: 15194576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
    Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Derivatives of dehydroepiandrosterone and their changes during a one-day starvation test].
    Matoulek M; Hampl R; Svacina S; Sulcová J; Haas T
    Cas Lek Cesk; 2000 Dec; 139(24):772-5. PubMed ID: 11262916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormones and lupus: defective dehydroepiandrosterone activity induces impaired interleukin-2 activity of T lymphocytes in patients with systemic lupus erythematosus.
    Suzuki N; Suzuki T; Sakane T
    Ann Med Interne (Paris); 1996; 147(4):248-52. PubMed ID: 8952743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.